Udaipur: The three-day national conference “Trends of Transformation in Oncology – Oncoconverge 2026” concluded with experts discussing emerging cancer treatments, fertility preservation, uro-oncology, immunotherapy and ways to improve patients’ quality of life.
The conference, organised around the theme “Breaking the Barriers – Research to Practice,” brought together oncology experts from across the country. While the first day focused on hematology, cancer-related medical complications and supportive care, the second day covered pathology, cardio-oncology, breast, lung, head and neck and gastrointestinal cancers. The final day focused on treatment as well as the long-term future and quality of life of cancer patients.
Immunotherapy and uro-oncology discussed
Programme Director Dr Manoj Mahajan said the third day began with an onco-endocrinology session focusing on endocrine side effects caused by immunotherapy and their management.
The uro-oncology session covered PSA screening for prostate cancer, overdiagnosis and early detection. Experts also discussed emerging treatment options for bladder cancer.
Focus on fertility preservation
One of the key discussions centred on fertility preservation among cancer patients. Experts discussed options such as sperm and oocyte cryopreservation before cancer treatment.
Dr Mahajan said cancer treatment is essential, but ensuring that patients can pursue their future aspirations after treatment is also an important responsibility of modern medicine.
Gynecological cancers also discussed
Dr Saurabh Sharma said the gynecologic oncology session covered the possibility of eliminating cervical cancer in India, the sequence of surgery and chemotherapy in ovarian cancer, and treatment approaches for metastatic endometrial cancer.
Experts also stressed the importance of awareness, prevention and timely diagnosis of cervical cancer to improve treatment outcomes.
Skin complications linked to immunotherapy
Dr Ankur Sharma said the concluding session focused on dermatological problems associated with immunotherapy, including their diagnosis and management. The conference concluded with closing remarks followed by lunch.
Dr Mahajan said the conference highlighted that the fight against cancer is not limited to medicines, machines and technology. Patients also need hope, the possibility of a future with their families and the opportunity to fulfil their aspirations.
He said the conference provided an important platform to bridge the gap between research and clinical practice. The exchange of knowledge and experience among experts reinforced the belief that although cancer remains a major challenge, advances in medical science, collaboration and human sensitivity can give the fight against the disease a new direction.
Bhupendra Singh Chundawat is a seasoned technology journalist with over 22 years of experience in the media industry. He specializes in covering the global technology landscape, with a deep focus on manufacturing trends and the geopolitical impact on tech companies. Currently serving as the Editor at Udaipur Kiran, his insights are shaped by decades of hands-on reporting and editorial leadership in the fast-evolving world of technology.